BRCA1 and ovarian cancer: The prevalence of BRCA1/2 mutation in general Chinese women (p1), the prevalence of breast/ovary cancer family history in general Chinese women (p50), and the BRCA1/2 mutation prevalence in FH + population (p51) were interrelated and affected the ICER of the FH-based strategy.